Table 2 Baseline characteristics of the combined training and internal validation cohort stratified by DILI status.

From: Development and external validation of a pre-treatment nomogram for predicting drug-induced liver injury risk in tuberculosis patients

Variables

Total

N = 2160 (%)

DILI

N = 108 (%)

Non-DILI

N = 2052 (%)

P  

Gender

   

0.740

 Female

752 (34.8)

36 (33.3)

716 (34.9)

 

 Male

1408 (65.2)

72 (66.7)

1336 (65.1)

 

Age (yrs)

   

 < 0.001

 < 60

929 (43.0)

28 (25.9)

901 (43.9)

 

 ≥ 60

1231 (57.0)

80 (74.1)

1151 (56.1)

 

BMI (kg/m2)

   

0.011

 < 18.5

627 (29.0)

43 (39.8)

584 (28.5)

 

 ≥ 18.5

1533 (71.0)

65 (60.2)

1468 (71.5)

 

Smoking

   

0.950

 No

1454 (67.3)

73 (67.6)

1381 (67.3)

 

 Yes

706 (32.7)

35 (32.4)

671 (32.7)

 

Drinking

   

 < 0.001

 No

1557 (72.1)

60 (55.6)

1497 (73.0)

 

 Yes

603 (27.9)

48 (44.4)

555 (27.0)

 

Diabetes

   

0.424

 No

1930 (89.4)

94 (87.0)

1836 (89.5)

 

 Yes

230 (10.6)

14 (13.0)

216 (10.5)

 

Hypertension

   

0.405

 No

1575 (72.9)

75 (69.4)

1500 (73.1)

 

 Yes

585 (27.1)

33 (30.6)

552 (26.9)

 

Extrapulmonary TB

   

0.001

 No

1482 (68.6)

58 (53.7)

1424 (69.4)

 

 Yes

678 (31.4)

50 (46.3)

628 (30.6)

 

Albumin (g/L)

   

 < 0.001

 < 35

490 (22.7)

45 (41.7)

445 (21.9)

 

 ≥ 35

1670 (77.3)

63 (58.3)

1607 (78.1)

 

WBC (× 109/L)

6.33 ± 2.61

6.23 ± 2.58

6.36 ± 2.52

0.602

RBC (109/L)

4.28 ± 2.41

4.21 ± 2.32

4.31 ± 2.28

0.657

HB (g/L)

   

0.003

 < 110

468 (21.7)

36 (33.3)

432 (21.1)

 

  ≥ 110

1692 (78.3)

72 (66.7)

1620 (78.9)

 

NEU (109/L)

4.83 ± 2.55

5.19 ± 2.96

4.80 ± 2.48

0.115

PLT (109/L)

225.12 ± 48.43

231.11 ± 52.14

223.20 ± 49.43

0.106

  1. DILI Drug-induced liver injury, BMI Body mass index, TB Tuberculosis, WBC White blood cell count, RBC Red blood cell count, HB Hemoglobin, NEU Neutrophil count, PLT, Platelet count.